Georg Gelbenegger

1.0k total citations
42 papers, 514 citations indexed

About

Georg Gelbenegger is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Epidemiology. According to data from OpenAlex, Georg Gelbenegger has authored 42 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 10 papers in Hematology and 9 papers in Epidemiology. Recurrent topics in Georg Gelbenegger's work include Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Georg Gelbenegger is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Georg Gelbenegger collaborates with scholars based in Austria, Poland and United States. Georg Gelbenegger's co-authors include Bernd Jilma, Christian Schoergenhofer, Jolanta M. Siller‐Matula, Nina Buchtele, Marek Postuła, Markus Zeitlinger, James C. Gilbert, Anselm Jorda, Ulla Derhaschnig and Shuhao Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Georg Gelbenegger

39 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg Gelbenegger Austria 14 145 125 90 76 68 42 514
Wojciech Sydor Poland 8 76 0.5× 119 1.0× 122 1.4× 42 0.6× 62 0.9× 25 433
Benjamin Oshrine United States 14 184 1.3× 224 1.8× 146 1.6× 57 0.8× 59 0.9× 39 590
Margit Tökés‐Füzesi Hungary 13 47 0.3× 245 2.0× 146 1.6× 121 1.6× 49 0.7× 26 498
Jayesh Jani United States 9 121 0.8× 144 1.2× 125 1.4× 29 0.4× 68 1.0× 15 491
Yuan‐Bin Yu Taiwan 12 154 1.1× 49 0.4× 50 0.6× 129 1.7× 80 1.2× 35 458
Kağan Huysal Türkiye 11 39 0.3× 120 1.0× 94 1.0× 42 0.6× 110 1.6× 35 577
Luděk Slavík Czechia 13 178 1.2× 169 1.4× 60 0.7× 64 0.8× 74 1.1× 63 549
Vasiliki Karlaftis Australia 11 150 1.0× 60 0.5× 86 1.0× 54 0.7× 50 0.7× 24 443
Esìn Beyan Türkiye 13 66 0.5× 65 0.5× 92 1.0× 52 0.7× 94 1.4× 46 412
Ksenija Stach Germany 12 42 0.3× 270 2.2× 82 0.9× 34 0.4× 37 0.5× 37 506

Countries citing papers authored by Georg Gelbenegger

Since Specialization
Citations

This map shows the geographic impact of Georg Gelbenegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Gelbenegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Gelbenegger more than expected).

Fields of papers citing papers by Georg Gelbenegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Gelbenegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Gelbenegger. The network helps show where Georg Gelbenegger may publish in the future.

Co-authorship network of co-authors of Georg Gelbenegger

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Gelbenegger. A scholar is included among the top collaborators of Georg Gelbenegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Gelbenegger. Georg Gelbenegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krenn, Katharina, Matthias Urban, Roman Ullrich, et al.. (2025). Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial. Anaesthesia Critical Care & Pain Medicine. 44(3). 101520–101520.
2.
Gelbenegger, Georg, Bernd Jilma, Jolanta M. Siller‐Matula, et al.. (2024). Landiolol for refractory ventricular fibrillation in out-of-hospital cardiac arrest: A randomized, double-blind, placebo-controlled, pilot trial. Resuscitation. 201. 110273–110273. 6 indexed citations
3.
Bergmann, Felix, et al.. (2024). Prevalence and clinical implications of bloodstream infections in intensive care patients with or without burn injury: a retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 43(9). 1731–1740. 1 indexed citations
4.
Zeitlinger, Markus, et al.. (2024). Association of Electrocardiogram Findings With Clinical Outcomes in Patients With Chronic Coronary Syndrome: An Analysis of the ISCHEMIA Trials. The American Journal of Medicine. 138(1). 61–69.e3. 2 indexed citations
5.
Schoergenhofer, Christian, Georg Gelbenegger, Christa Firbas, et al.. (2024). A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results. EClinicalMedicine. 67. 102404–102404. 5 indexed citations
6.
Bergmann, Felix, et al.. (2023). Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials. Clinical Infectious Diseases. 77(12). 1704–1713. 10 indexed citations
7.
Müeller, Matthias, Heidrun Losert, Fritz Sterz, et al.. (2023). Prehospital emergency medicine research by additional teams on scene – Concepts and lessons learned. Resuscitation Plus. 16. 100494–100494. 5 indexed citations
8.
Jorda, Anselm, Cornelia Gabler, Georg Gelbenegger, et al.. (2023). Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study. Infection. 52(1). 105–115. 9 indexed citations
9.
Bergmann, Felix, Arthur Hosmann, Stefan Greisenegger, et al.. (2023). Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trials. Vascular Pharmacology. 150. 107177–107177. 6 indexed citations
10.
Ay, Cihan, Christian Schoergenhofer, Georg Gelbenegger, et al.. (2022). The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A. Blood. 141(10). 1147–1158. 18 indexed citations
11.
Ay, Cihan, Ingrid Pabinger, Georg Gelbenegger, et al.. (2022). The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. Blood Advances. 6(18). 5467–5476. 20 indexed citations
12.
Gelbenegger, Georg, Juergen Grafeneder, Gloria M. Gager, et al.. (2022). Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial. Thrombosis Journal. 20(1). 19–19. 4 indexed citations
13.
Jorda, Anselm, Manuel Kussmann, Jolanta M. Siller‐Matula, et al.. (2022). Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 817829–817829. 28 indexed citations
14.
Grafeneder, Juergen, Alexandra-Maria Warenits, Nina Buchtele, et al.. (2022). Multi-phasic life-threatening anaphylaxis refractory to epinephrine managed by extracorporeal membrane oxygenation (ECMO): A case report. SHILAP Revista de lepidopterología. 3. 934436–934436. 6 indexed citations
15.
Grafeneder, Juergen, Christian Schörgenhofer, Georg Gelbenegger, et al.. (2021). The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial. Haematologica. 107(9). 2121–2132. 28 indexed citations
16.
Greisenegger, Stefan, A. Langer, Georg Gelbenegger, et al.. (2021). The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients. Scientific Reports. 11(1). 3092–3092. 25 indexed citations
17.
Jorda, Anselm, Jolanta M. Siller‐Matula, Markus Zeitlinger, Bernd Jilma, & Georg Gelbenegger. (2021). Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis. Clinical Pharmacology & Therapeutics. 111(3). 614–623. 18 indexed citations
18.
Grafeneder, Juergen, Konstantin A. Krychtiuk, Nina Buchtele, et al.. (2020). The ISTH DIC score predicts outcome in non-septic patients admitted to a cardiovascular intensive care unit. European Journal of Internal Medicine. 79. 37–42. 11 indexed citations
19.
Schoergenhofer, Christian, Nina Buchtele, Georg Gelbenegger, et al.. (2019). Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers. Scientific Reports. 9(1). 11136–11136. 8 indexed citations
20.
Gelbenegger, Georg, Marek Postuła, Ladislav Pecen, et al.. (2019). Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups. BMC Medicine. 17(1). 198–198. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wojciech Sydor Breakdown of academic impact, for papers by Benjamin Oshrine Breakdown of academic impact, for papers by Margit Tökés‐Füzesi Breakdown of academic impact, for papers by Jayesh Jani Breakdown of academic impact, for papers by Yuan‐Bin Yu Breakdown of academic impact, for papers by Kağan Huysal Breakdown of academic impact, for papers by Luděk Slavík Breakdown of academic impact, for papers by Vasiliki Karlaftis Breakdown of academic impact, for papers by Esìn Beyan Breakdown of academic impact, for papers by Ksenija Stach
Rankless by CCL
2026